Nicole R. Hadas, SVP, Chief Legal Officer at Akebia Therapeutics, Inc. (AKBA), sold 21,062 shares at $2.17 ($46K) on 2022-03-01, disclosed to the SEC on 2022-03-02.
Seasonal sale ($46k) by SVP, Chief Legal Officer — this insider has traded AKBA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.15 | 6,555 | $14K | 30.9% |
| 2 | $2.17 | 1,078 | $2K | 5.1% |
| 3 | $2.17 | 6,556 | $14K | 31.2% |
| 4 | $2.17 | 6,873 | $15K | 32.7% |
| Total | $2.16 avg | 21,062 | $46K | 100% |
| Filing → |
| AKBA | SELL | 2024-02-29 | $11K | — | Filing → |
| AKBA | SELL | 2023-05-25 | $154K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $11K | — | Filing → |